Gilgamesh Pharma

Gilgamesh Pharma is a clinical-stage biotech company operating in the New York AI scene [1]. Founded in 2019, the company focuses on reshaping treatment approaches for mental illnesses [2]. Rather than emphasizing symptom management, Gilgamesh's vision centers on developing rapid-acting and durable therapies that target the fundamental drivers of disease [2]. The company designs new chemical entities acting through proven mechanisms, with optimization for safety, efficacy, and patient access [2]. Gilgamesh operates in the pharmaceutical manufacturing industry [3] and maintains a workforce of approximately 35 employees [3].

Something wrong or missing? Send a correction. Fixed within 24 hours.